CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing
Essays in Biochemistry · 18.11.2024 · 68 (3) · 309-320
DOI: 10.1042/ebc20240011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Essays in Biochemistry, online erschienen am 18.11.2024. Verfasst von Luke M McAloon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Kinase, Calcium Signaling, Energy Metabolism. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC), Australian Research Council (ARC).
Abstract (Originalsprache)
Calcium (Ca2+) ions are ubiquitous and indispensable signaling messengers that regulate virtually every cell function. The unique ability of Ca2+ to regulate so many different processes yet cause stimulus specific changes in cell function requires sensing and decoding of Ca2+ signals. Ca2+-sensing proteins, such as calmodulin, decode Ca2+ signals by binding and modifying the function of a diverse range of effector proteins. These effectors include the Ca2+-calmodulin dependent protein kinase kinase-2 (CaMKK2) enzyme, which is the core component of a signaling cascade that plays a key role in important physiological and pathophysiological processes, including brain function and cancer. In addition to its role as a Ca2+ signal decoder, CaMKK2 also serves as an important junction point that connects Ca2+ signaling with energy metabolism. By activating the metabolic regulator AMP-activated protein kinase (AMPK), CaMKK2 integrates Ca2+ signals with cellular energy status, enabling the synchronization of cellular activities regulated by Ca2+ with energy availability. Here, we review the structure, regulation, and function of CaMKK2 and discuss its potential as a treatment target for neurological disorders, metabolic disease, and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia.
- Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Parkville, Victoria 3052, Australia.
- Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, U.S.A.
- St Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia.
ORCID-Profile: John W Scott
Förderung
- National Health and Medical Research Council (NHMRC)
- Australian Research Council (ARC)
Zitieren
APA
McAloon, L. M., Muller, A. G., Nay, K., Lu, E. L., Smeuninx, B., Means, A. R., Febbraio, M. A., & Scott, J. W. (2024). CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing. Essays in Biochemistry, 68(3), 309-320. https://doi.org/10.1042/ebc20240011
Vancouver
McAloon LM, Muller AG, Nay K, Lu EL, Smeuninx B, Means AR, et al. CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing. Essays in Biochemistry. 2024;68(3):309-320. doi:10.1042/ebc20240011
BibTeX
@article{McAloon2024,
author = {McAloon, Luke M and Muller, Abbey G and Nay, Kevin and Lu, Eudora L and Smeuninx, Benoit and Means, Anthony R and Febbraio, Mark A and Scott, John W},
title = {CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing},
journal = {Essays in Biochemistry},
year = {2024},
volume = {68},
number = {3},
pages = {309--320},
doi = {10.1042/ebc20240011}
}
EUVIMED